(Q40645849)

22 September 2017

1 reference

title

Amphotericin B lipid complex (English)

1 reference

22 September 2017

1 reference

R P Rapp

1

1 reference

22 September 2017

P O Gubbins

series ordinal

2

1 reference

22 September 2017

M E Evans

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

Annals of Pharmacotherapy

22 September 2017

1 reference

22 September 2017

31

1 reference

22 September 2017

10

1 reference

22 September 2017

1174-1186

1 reference

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

22 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Amphotericin B: current understanding of mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Strategies in the treatment of systemic fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Rapid intravenous infusion of amphotericin B: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Molecular Aspects of Polyene- and Sterol-Dependent Pore Formation in Thin Lipid Membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Amphotericin B induces tumor necrosis factor production by murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Immunomodulating activity of antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Amphotericin B lipid complex therapy of experimental fungal infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Amphotericin B Pharmacokinetics in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Successful treatment of invasive aspergillosis complicating prolonged treatment-related neutropenia in acute myelogenous leukemia with amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Use of amphotericin B lipid complex for treatment of disseminated cutaneous fusarium infection in a neutropenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101011

10.1177/106002809703101011

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference